News | Radiation Therapy | September 22, 2017

Penn Medicine Treats World's First Patient on Varian's Halcyon System

Head & neck cancer patient treated in just 13 minutes with advanced platform

Penn Medicine Treats World's First Patient on Varian's Halcyon System

September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became the first person in the world to be treated on Varian's new Halcyon radiation therapy platform. Halcyon is well suited to handle the majority of cancer patients, according to the company, offering advanced treatments for prostate, breast, head & neck, and many other forms of cancer.

The treatment for this patient at Penn Medicine was a complex case that involved the delivery of nine fields. The total patient time in the treatment room, including set-up, imaging, three minutes of beam time and patient discharge, was only 13 minutes. Typically, a treatment like this using other radiation technology can take 10 minutes of beam time and 20 minutes total treatment time.

Halcyon is an advanced system that is more comfortable for the patient while delivering ease of use for healthcare providers, accelerated installation timeframes, expedited commissioning, simplified training and automated treatment.

"We are proud to have delivered the world's first Halcyon treatment, which contributes to our ongoing mission to provide patients the widest and most advanced array of cancer treatment options," said James Metz, M.D., chair of radiation oncology at Penn Medicine. "This platform combines reduced treatment time with simplified operation, and for some diseases, it even lets us be more precise with the radiation we're delivering."

For more information: www.varian.com

Related Content

Mevion Achieves CE Mark for S250i Proton Therapy System
News | Proton Therapy | November 21, 2017
November 21, 2017 — Mevion Medical Systems announced the Mevion S250i...
RayStation Selected for New Tennessee Proton Therapy Center
News | Treatment Planning | November 20, 2017
November 20, 2017 — Provision Healthcare has selected RayStation for external beam planning at the new Provision Care
Sponsored Content | Videos | Radiation Therapy | November 15, 2017
Chris Toth, president, global commercial and field operations for Varian, takes a tour of Varian’s new product introd
Synthetic CT Images Suitable for Prostate Cancer Radiotherapy Planning
News | Treatment Planning | November 14, 2017
Spectronic Medical announced that new data for their MRIPlanner software, generating synthetic computed tomography (sCT...
ASTRO: CMS Report on Radiation Therapy Payment Model Charts Path to Value-Based Cancer Care
News | Radiation Therapy | November 08, 2017
The American Society for Radiation Oncology (ASTRO) called on the Centers for Medicare and Medicaid Services (CMS) to...
U.S. Recognizes Radiologic Technologists Nov. 5-11
News | Imaging | November 06, 2017
November 6, 2017 — During National Radiologic Technology Week (NRTW) every November, hospitals, healthcare centers an
Study Suggests Breast Cancer Patients Forego Post-Surgery Treatment Due to Mistrust
News | Radiation Therapy | November 06, 2017
November 6, 2017 — Nearly one-third of women with...
PTCOG-NA Studies Address Cost and Coverage Issues With Proton Therapy
News | Proton Therapy | November 01, 2017
Physicians from across the country gathered in Chicago last week to discuss the most recent advances in proton therapy...
Proton Therapy Lowers Treatment Side Effects in Pediatric Head and Neck Cancer Patients
News | Proton Therapy | November 01, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional...
Cleveland Clinic Leads Development of New Guidelines for Radiation in Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 31, 2017
October 31, 2017 — Cleveland Clinic researcher Chirag Shah, M.D., recently led the development of updated guidelines
Overlay Init